GPT-Rosalind Agents Surface New Neurodegeneration Leads in Mouse-Brain Data

Key Info

OpenAI's GPT-Rosalind, in collaboration with PerturbAI and Scripps Research, deployed thousands of parallel agents to analyze mouse-brain gene-expression data, surfacing mechanistic leads for two neurodegenerative conditions.

Highlights

• For DCTN1, a gene linked to Perry syndrome, disrupting it increased expression of cholesterol-making genes; GPT-Rosalind suggested cholesterol may not be reaching where neurons need it, offering a testable mechanism.
• In the same dataset, GPT-Rosalind found a possible clue to why TSC2 mutations cause more severe tuberous sclerosis than TSC1: disrupting TSC2 altered dozens of genes in one cerebellar neuron group, while TSC1 disruption had little effect.
• The team connected gene-expression results from millions of data points using thousands of agents working in parallel.
• The findings give scientists specific mechanisms to test and potential directions for new treatments.